EQH Stock Analysis: Axa Equitable Holdings | NYSE
Asset Management | NYSE, USA | Market Cap: 15.068m USD | 12M Return: 20.2% | US29452E1010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 139M
EPS Trend: 82.6%
Qual. Beats: 1
Rev. Trend: 27.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Equitable Holdings, Inc. (EQH) is a diversified financial services company that operates through six segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. The company provides variable annuity products, retirement plan services, investment management, life insurance, employee benefits, and wealth advisory services, serving clients ranging from individual retail and high-net-worth investors to institutions, small and medium-sized businesses, and tax-exempt entities. The Legacy segment includes capital-intensive fixed-rate guaranteed minimum withdrawal benefit (GMxB) business. Founded in 1859 and headquartered in New York, the company is the result of AXAs U.S. operations and rebranded from AXA Equitable Holdings to Equitable Holdings in January 2020.
Within the GICS Diversified Financial Services sub-industry, EQH operates across multiple insurance and asset management verticals, including variable annuities, life insurance, and institutional investment management. The Diversified Financial Services sub-industry generally includes companies with business lines spanning insurance, asset management, and capital markets activities, often generating revenue through premium income, asset-based fees, and advisory charges.
- Variable annuity sales fuel Individual Retirement fee growth
- Net investment income tracks Federal Reserve rate path
- Legacy GMxB runoff frees capital and reduces hedge costs
- Asset management fees swing with equity market levels
| Net Income: 1.50b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.06 > 1.0 |
| NWC/Revenue: -930.1% < 20% (prev -510.1%; Δ -420.0% < -1%) |
| CFO/TA 0.00 > 3% & CFO 1.43b > Net Income 1.50b |
| Net Debt (-11.0b) to EBITDA (2.21b): -4.97 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (526.3m) vs 12m ago 73.58% < -2% |
| Gross Margin: 85.22% > 18% (prev 53.39%; Δ 31.83% > 0.5%) |
| Asset Turnover: 4.02% > 50% (prev 3.61%; Δ 0.42% > 0%) |
| Interest Coverage Ratio: 6.06 > 6 (EBIT TTM 1.33b / Interest Expense TTM 220.0m) |
| A: -0.36 (Total Current Assets 17.5b - Total Current Liabilities 139b) / Total Assets 334b |
| B: 0.03 (Retained Earnings 9.25b / Total Assets 334b) |
| C: 0.00 (EBIT TTM 1.33b / Avg Total Assets 324b) |
| D: -0.01 (Book Value of Equity -1.80b / Total Liabilities 334b) |
| Altman-Z'' = -2.27 = D |
As of November 07, 2026, the stock is trading at USD 52.91 with a total of 2,118,347 shares traded. Over the past week, the price has changed by -3.11%, over one month by -2.02%, over three months by +3.14% and over the past year by +20.15%.
Current recommended Stop Loss: 50.60 (which is 4.4% or 1.4 ATR below the current price).
Axa Equitable Holdings has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy EQH.
- StrongBuy: 9
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 64 | 21% |
P/E Trailing = 10.8955
P/E Forward = 5.8173
P/S = 1.4188
P/B = 164.1395
Revenue TTM = 13.0b USD
EBIT TTM = 1.33b USD
EBITDA TTM = 2.21b USD
Long Term Debt = 6.54b USD (from longTermDebt, last fiscal year)
Short Term Debt = 25.0m USD (from shortTermDebt, last fiscal year)
Debt = 6.56b USD (corrected: LT Debt 6.54b + ST Debt 25.0m)
Net Debt = -11.0b USD (calculated: Debt 6.56b - CCE 17.5b)
Enterprise Value = 4.10b USD (15.1b + Debt 6.56b - CCE 17.5b)
Interest Coverage Ratio = 6.06 (Ebit TTM 1.33b / Interest Expense TTM 220.0m)
EV/FCF = 2.94x (Enterprise Value 4.10b / FCF TTM 1.40b)
FCF Yield = 34.00% (FCF TTM 1.40b / Enterprise Value 4.10b)
FCF Margin = 10.69% (FCF TTM 1.40b / Revenue TTM 13.0b)
Net Margin = 11.53% (Net Income TTM 1.50b / Revenue TTM 13.0b)
Gross Margin = 85.22% ((Revenue TTM 13.0b - Cost of Revenue TTM 1.93b) / Revenue TTM)
Gross Margin QoQ = 81.37% (prev 74.67%)
Tobins Q-Ratio = 0.01 (Enterprise Value 4.10b / Total Assets 334b)
Interest Expense / Debt = 3.35% (Interest Expense 220.0m / Debt 6.56b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 1.05b (EBIT 1.33b * (1 - 21.00%))
Current Ratio = 0.13 (Total Current Assets 17.5b / Total Current Liabilities 139b)
Debt / Equity = -3.64 (negative equity) (Debt 6.56b / totalStockholderEquity, last quarter -1.80b)
Debt / EBITDA = -4.97 (Net Debt -11.0b / EBITDA 2.21b)
Debt / FCF = -7.86 (Net Debt -11.0b / FCF TTM 1.40b)
Total Stockholder Equity = -597.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.46% (Net Income 1.50b / Total Assets 334b)
RoE = -251.8% (negative equity) (Net Income TTM 1.50b / Total Stockholder Equity -597.2m)
RoCE = 22.44% (EBIT 1.33b / Capital Employed (Equity -597.2m + L.T.Debt 6.54b))
RoIC = 0.54% (NOPAT 1.05b / Invested Capital 195b)
WACC = 7.32% (E(15.1b)/V(21.6b) * Re(9.36%) + D(6.56b)/V(21.6b) * Rd(3.35%) * (1-Tc(0.21)))
Discount Rate = 9.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 32.52 | Cagr: 23.50%
[DCF] Terminal Value 74.49% ; FCFF base≈1.43b ; Y1≈1.36b ; Y5≈1.29b
[DCF] Fair Price = 114.4 (EV 20.2b - Net Debt -11.0b = Equity 31.2b / Shares 272.8m; r=8.35% [WACC [floored]]; 5y FCF grow -6.63% → 2.50% )
EPS Correlation: 82.61 | EPS CAGR: 10.97% | SUE: 2.84 | # QB: 1
Revenue Correlation: 27.93 | Revenue CAGR: 3.02% | SUE: -0.06 | # QB: 0
EPS current Year (2026-12-31): EPS=7.15 | Chg30d=-0.28% | Revisions=-36% | GrowthEPS=+26.8% | GrowthRev=+33.3%
EPS next Year (2027-12-31): EPS=8.91 | Chg30d=-1.13% | Revisions=+0% | GrowthEPS=+24.6% | GrowthRev=+10.3%
[Analyst] Revisions Ratio: -21% (up=6, down=10)